April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Patient Comfort With 30-Gauge versus 31-Gauge Intravitreal Injection
Author Affiliations & Notes
  • A. R. Gohari
    Ophthalmology/Retina,
    Retina Associates, New Orleans, Louisiana
  • R. L. Willson
    Retina,
    Retina Associates, New Orleans, Louisiana
  • G. M. Cousins
    Retina,
    Retina Associates, New Orleans, Louisiana
  • G. Cohen
    Retina,
    Retina Associates, New Orleans, Louisiana
  • K. A. Gitter
    Retina,
    Retina Associates, New Orleans, Louisiana
  • Footnotes
    Commercial Relationships  A.R. Gohari, None; R.L. Willson, None; G.M. Cousins, None; G. Cohen, None; K.A. Gitter, None.
  • Footnotes
    Support  The Foundation for Retinal Research
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 4196. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. R. Gohari, R. L. Willson, G. M. Cousins, G. Cohen, K. A. Gitter; Patient Comfort With 30-Gauge versus 31-Gauge Intravitreal Injection. Invest. Ophthalmol. Vis. Sci. 2009;50(13):4196.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To study the effect of needle size (30-gauge versus 31-gauge) on patient self-reported pain scale (0-10).

Methods: : Prospective study of forty seven patients who received intravitreal injections by two surgeons at two clinic sites. IRB approval was obtained prior to study. Patient participation was completely voluntary. Exclusion criteria included severe dementia, inability to rate pain on a standard 1-10 scale, and baseline ocular pain prior to injection. The decision to perform intravitreal injection was solely based each patient’s underlying diagnosis confirmed by slit lamp biomicroscopy, indirect ophthalmoscopy, optical coherence tomography, and intravenous flourescence angiography. Patients were asked to rate their pain associated with intravitreal injection immediately after the procedure on a standard 0-10 scale with zero indicating no perception of pain. The method of topical anesthesia was identical for all patients. The two intravitreal medications that were administered in this study included triamcinolone acetonide and bevacizumab.

Results: : The average age in this study was seventy seven. Sixty two percent of the participants were female and 38% were male. The average patient-reported pain score on a scale of 0-10 was 3.3±3.0 with zero corresponding to no perception of pain. The patients who underwent intravitreal injection of pharmacologic agent with a 30-gauge needle (n = 13) reported an average pain score of 3.8±2.9. Those who received intravitreal injections with a 31-gauge needle (n = 34) reported an average pain score of 3.1±3.0. There was no statistically significant difference between the pain scores when comparing the 30-gauge needle to 31-gauge needle for the administeration of intravitreal medication. None of the patients in this study experienced complications such as retinal detachment or endophthalmitis.

Conclusions: : Most patients tolerate intravitreal injections well with a relatively low average pain score of 3.3±3.0 on a scale of 0-10. No statistically signifiant difference was detected when comparing average pain scores between the 30-gauge group and the 31-gauge group.

Keywords: vitreoretinal surgery • retina • clinical (human) or epidemiologic studies: outcomes/complications 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×